![A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies | BMC Dermatology | Full Text A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies | BMC Dermatology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12895-019-0088-2/MediaObjects/12895_2019_88_Fig1_HTML.png)
A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies | BMC Dermatology | Full Text
![Global Assessment of Psoriasis Severity and Change from Photographs: A Valid and Consistent Method - ScienceDirect Global Assessment of Psoriasis Severity and Change from Photographs: A Valid and Consistent Method - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022202X1534032X-gr3.gif)
Global Assessment of Psoriasis Severity and Change from Photographs: A Valid and Consistent Method - ScienceDirect
![Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/44/4/519/F2.large.jpg)
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
![Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2 - JDDonline - Journal of Drugs in Dermatology Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2 - JDDonline - Journal of Drugs in Dermatology](https://s3.amazonaws.com/dl.jddonline.com/articleimages/article_3181/table1.jpg)
Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2 - JDDonline - Journal of Drugs in Dermatology
Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity
![Coverage area (%) estimation module for psoriasis area and severity... | Download Scientific Diagram Coverage area (%) estimation module for psoriasis area and severity... | Download Scientific Diagram](https://www.researchgate.net/profile/Sang-Woong-Youn/publication/283326359/figure/fig1/AS:614273302659079@1523465576302/Coverage-area-estimation-module-for-psoriasis-area-and-severity-index-body-surface_Q640.jpg)
Coverage area (%) estimation module for psoriasis area and severity... | Download Scientific Diagram
![Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds ... Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds ...](https://onlinelibrary.wiley.com/cms/asset/0ba7630e-b023-4a9e-90de-3b74d596eb00/mfig001.jpg)
Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds ...
![Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis](https://www.jhrr.org/articles/2018/5/2/images/JHealthResRev_2018_5_2_86_238863_f1.jpg)
Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis
![Coverage area (%) estimation module for psoriasis area and severity... | Download Scientific Diagram Coverage area (%) estimation module for psoriasis area and severity... | Download Scientific Diagram](https://www.researchgate.net/publication/283326359/figure/fig1/AS:614273302659079@1523465576302/Coverage-area-estimation-module-for-psoriasis-area-and-severity-index-body-surface.png)